A two-year study to validate a test to detect early-stage liver cancer has been initiated by the National Cancer Institute (NCI), part of the National Institutes of Health, at six centers* across the United States. This test, conceived with the assistance of NCI’s Early Detection Research Network (EDRN), looks at whether a substance called des-gamma […]

According to research from the National Cancer Institute (NCI), part of the National Institutes of Health, men who receive a reproducible prostate specific antigen (PSA) test result of 7 ng/ml (nanograms per milliliter) or greater are more likely to have a subsequent prostate biopsy compared to men with lower but still abnormal test results. Men […]

Researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have found that zinc deficiency in humans is associated with an increased risk of developing esophageal squamous cell carcinoma, an often-fatal form of esophageal cancer that has about 7,000 cases a year. NCI researchers used a novel approach to measure the […]

The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has released a new software tool that will facilitate the sharing and analysis of microarray data by the medical research community. Microarray technology has many applications in cancer research, including identifying novel genes associated with certain cancers, classifying tumors, and predicting patient […]